Advertisement: Mobas mid banner
Advertisement: Cambridge Network
RealVNC mid banner careers
Advertisement: RSM
Advertisement: Bradfield Centre mid
Advertisement: Lynch Wood Park
ARM Innovation Hub
Advertisement: Bridge Fibre mid
RealVNC mid-banner general
Advertisement: EY
Advertisement Cambridge China Centre
Barr Ellison Solicitors – commercial property
12 December, 2018 - 02:20 By Kate Sweeney

Cambridge personalised cancer app wins accolade

An online application that advises patients and clinicians on the best treatment combinations for breast cancer, based on personal data and previous outcomes, has won a research excellence award.

Predict, developed by a team of Cambridge-based clinicians and scientists led by Gordon Wishart, Visiting Professor at Anglia Ruskin University’s School of Medicine, won the People’s Choice category at the Office of National Statistics’ inaugural Research Excellence Awards.

Since its launch in 2010, Predict has helped almost 1,000,000 doctors and patients worldwide decide whether chemotherapy should be prescribed or not. It is the only breast cancer model currently endorsed by the American Joint Committee on Cancer.

The model works by assessing a number of input variables, such as age at diagnosis, tumour size/grade and how it was detected. It then uses statistical models to inform clinicians and patients of the treatment combination that is most likely to succeed.

Newsletter Subscription

Stay informed of the latest news and features